Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress Syndrome*
- 1 December 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 47 (12) , 1724-1734
Abstract
Objectives: Classification of patients with acute respiratory distress syndrome into hyper- and hypoinflammatory subphenotypes using plasma biomarkers may facilitate more effective targeted therapy. We examined whether established subphenotypes are present not only in patients with acute respiratory distress syndrome but also in patients at risk for acute respiratory distress syndrome (ARFA) and then assessed the prognostic information of baseline subphenotyping on the evolution of host-response biomarkers and clinical outcomes. Design: Prospective, observational cohort study. Setting: Medical ICU at a tertiary academic medical center. Patients: Mechanically ventilated patients with acute respiratory distress syndrome or ARFA. Interventions: None. Measurements and Main Results: We performed longitudinal measurements of 10 plasma biomarkers of host injury and inflammation. We applied unsupervised latent class analysis methods utilizing baseline clinical and biomarker variables and demonstrated that two-class models (hyper- vs hypoinflammatory subphenotypes) offered improved fit compared with one-class models in both patients with acute respiratory distress syndrome and ARFA. Baseline assignment to the hyperinflammatory subphenotype (39/104 [38%] acute respiratory distress syndrome and 30/108 [28%] ARFA patients) was associated with higher severity of illness by Sequential Organ Failure Assessment scores and incidence of acute kidney injury in patients with acute respiratory distress syndrome, as well as higher 30-day mortality and longer duration of mechanical ventilation in ARFA patients (p < 0.0001). Hyperinflammatory patients exhibited persistent elevation of biomarkers of innate immunity for up to 2 weeks postintubation. Conclusions: Our results suggest that two distinct subphenotypes are present not only in patients with established acute respiratory distress syndrome but also in patients at risk for its development. Hyperinflammatory classification at baseline is associated with higher severity of illness, worse clinical outcomes, and trajectories of persistently elevated biomarkers of host injury and inflammation during acute critical illness compared with hypoinflammatory patients. Our findings provide strong rationale for examining treatment effect modifications by subphenotypes in randomized clinical trials to inform precision therapeutic approaches in critical care.Keywords
This publication has 31 references indexed in Scilit:
- Prognostic value of procalcitonin in pneumonia: A systematic review and meta‐analysisRespirology, 2015
- Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patientsCritical Care, 2015
- Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical CareAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trialsThe Lancet Respiratory Medicine, 2014
- Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress SyndromeCritical Care Medicine, 2013
- A comparison of Cohen’s Kappa and Gwet’s AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samplesBMC Medical Research Methodology, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- Plasma angiopoietin-2 in clinical acute lung injuryCritical Care Medicine, 2012
- Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity*Critical Care Medicine, 2008
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007